Latest Biotechnology, Pharmaceutical and Healthcare News from Globes

02:48 EST 16th December 2018 | BioPortfolio

Here are the most relevant search results for "Globes" found in our extensive news archives from over 250 global news sources.

More Information about Globes on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Globes for you to read. Along with our medical data and news we also list Globes Clinical Trials, which are updated daily. BioPortfolio also has a large database of Globes Companies for you to search.

Showing News Articles 1–25 of 276 from Globes

Friday 14th December 2018

FDA approves Check-Cap colon cancer capsule screening trial

The study will evaluate the safety, usability, and subject compliance of the C-Scan system.

Thursday 13th December 2018

Teva to build new headquarters in Tel Aviv

The pharmaceutical giant has bought land in Ramat Hahayal and will be moving its head office there from Petah Tikva in mid-2020.

Israeli microbiome co BiomX teams with J&J

BiomX's XMarker microbiome-based biomarker discovery platform will be used to stratify responders and non-responders to inflammatory bowel disease therapeutics.

Wednesday 12th December 2018

Cannbit signs collaboration agreement with Namaste

The companies will register Cannbit for overseas trading and dual-listing of Namaste on the TASE.

Tuesday 11th December 2018

HeraMED raises NIS 16m in Australian IPO

HeraMED has developed a small monitor for home use that tracks fetal heartbeats.

Digital diagnostic lab co EfA raises $900,000

Engineering for All has become the 8th portfolio company in the eHealth Ventures technological incubator.

Heart failure treatment co WhiteSwell raises $30m

The company is developing a minimally invasive catheter-based approach to treat acute decompensated heart failure.

Entera Bio signs $270m Amgen licensing deal

Entera will use its proprietary drug delivery platform to develop oral formulations for one preclinical large molecule program in inflammatory diseases and other serious illnesses that Amgen has selected.

Teva could be hit by huge fine on US cartel probe

Teva is reportedly being investigated in the US for allegedly forming a cartel and fixing prices for 300 drugs.

Israeli medical device co Alpha Omega in Chinese JV

GIBF is investing $7 million in the joint venture with Nazareth-based Alpha Omega, which produces devices for deep brain stimulation surgery.

Monday 10th December 2018

US drug cartel probe names Teva

"The Washington Post" reports that prosecutors are investigating "the largest cartel in the history of the US." Teva: The allegations are devoid of facts.

Sunday 9th December 2018

RedHill Biopharma raises $20m on Nasdaq

The Israeli company will use the funds for the commercial launch of H.pylori drug TALICIA and two phase III clinical trials.

Wednesday 5th December 2018

Medtronic CEO attends Tel Aviv conference

Omar Ishrak was a guest of honor at the International Conference for Innovations in Cardiovascular Systems.

Cannbit to sell medical cannabis to Tikun Olam

Tikun Olam will be short of cannabis until its Kfar Yehoshua farms is approved.

Tuesday 4th December 2018

Medical cannabis export bill passes first Knesset reading

Even if the bill passes until law, its implementation will still depend on Prime Minister Benjamin Netanyahu giving the green light.

Sunday 2nd December 2018

Medtronic CEO visits Israel

Omar Ishrak heads a delegation of senior executives who will become acquainted with Medtronics recent acquisitions - Mazor Robotics, Nutrino and Visionsense.

Thursday 29th November 2018

Hadassah, IBM set up digital health accelerator

The program will give companies easy access to hospital resources and technological assistance.

Teva, Celltrion win FDA approval for Rituxan biosimilar

The companies have not announced a date for launching their version of the non-Hodgkin's Disease lymphoma treastment.

Wednesday 28th November 2018

WeWork's Adam Neumann invests in cannabis co InterCure

Billionaire Gary Fegel, an associate of InterCure chairperson and former Prime Minister Ehud Barak, led the $5 million round.

Teva begins selling generic EpiPen

The treatment for life-threatening allergies has been the flagship branded drug of Mylan, Teva's generic pharmaceutical rival.

Tuesday 27th November 2018

Cannabis co Panaxia to merge into stock market shell

Following cancelation of the deal for merging Brown Hotels into it, stock exchange shell Herodium has found an alternative.

Monday 26th November 2018

Merchavia signs MoU for first medical cannabis investment

Merchavia is investing $400,000 for 20% of an Israeli company, which has developed unique technology for inhaling precise doses of cannabis.

Sunday 25th November 2018

Teva's loss is Israeli pharma industry's gain

Disinvestment by Teva from Israeli drug development companies and thousands of employees laid off have had advantages for Israel's pharma industry.

Wednesday 21st November 2018

Medtronic buys Israeli nutrition data co Nutrino

The Tel Aviv-based nutrition-relateddata services, analytics,and technologies company will be integrated into Medtronic's Diabetes Group.

CVC set to buy Israeli medical device co Lumenis for $1b

Private equity fund XIO acquired the Yokneam-based aesthetic medical device company in 2015 for $520 million.

Quick Search


News Quicklinks